Correlation Engine 2.0
Clear Search sequence regions


  • adult (1)
  • breast cancer (1)
  • cancer (2)
  • cell (9)
  • central nervous system (1)
  • cisplatin (1)
  • cpg islands (2)
  • dna (2)
  • female (1)
  • FGF8 (1)
  • genes (4)
  • growth (1)
  • growth factor (1)
  • human (2)
  • morphogenesis (1)
  • ovarian cancer (3)
  • ovarian tumor (5)
  • ovary (1)
  • patient (3)
  • phenotypes (1)
  • prognostic (1)
  • rna (2)
  • state drug (1)
  • Teneurin 2 (7)
  • Teneurin 4 (9)
  • teneurins (3)
  • tissue (3)
  • transcript (1)
  • Sizes of these terms reflect their relevance to your search.

    Teneurins are a family of highly conserved pair-rule proteins involved in morphogenesis and development of the central nervous system. Their function in adult tissues and in disease is largely unknown. Recent evidence suggests a role for dysregulated expression of Teneurins in human tumors, but systematic investigations are missing. Here, we investigated Teneurin-2 and Teneurin-4 expression in various cancer cell lines and in ovarian tumor tissues. Teneurin-2 and Teneurin-4 were expressed in most of the breast cancer cell lines tested. Teneurin-4 was also detected in ovarian cancer cell lines, and throughout ovarian tumors and normal ovary tissue. Ovarian tumors with low Teneurin-4 expression showed less differentiated phenotypes and these patients had shorter mean overall survival. Similarly, Teneurin-2 expression correlated with overall survival as well, especially in patients with serous tumors. In the various cell lines, 5-Aza-cytidine-induced changes in DNA methylation did not alter expression of Teneurin-2 and Teneurin-4, despite the existence of predicted CpG islands in both genes. Interestingly, however, we found evidence for the control of Teneurin-2 expression by the oncogenic growth factor FGF8. Furthermore, we identified multiple transcript splicing variants for Teneurin-2 and Teneurin-4, indicating complex gene expression patterns in malignant cells. Finally, downregulation of Teneurin-4 expression using siRNA caused a cell-type dependent increase in proliferation and resistance to cisplatin. Altogether, our data suggest that low Teneurin-4 expression provides a growth advantage to cancer cells and marks an undifferentiated state characterized by increased drug resistance and clinical aggressiveness. We conclude that Teneurin-2 and Teneurin-4 expression levels could be of prognostic value in ovarian cancer.

    Citation

    Rebecca Graumann, Gabriella A Di Capua, Juan E Oyarzún, Marcos A Vásquez, Christine Liao, Jorge A Brañes, Iván Roa, Paola Casanello, Alejandro H Corvalán, Gareth I Owen, Iris Delgado, Uwe Zangemeister-Wittke, Annemarie Ziegler. Expression of teneurins is associated with tumor differentiation and patient survival in ovarian cancer. PloS one. 2017;12(5):e0177244

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 28472127

    View Full Text